AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 271 min read$THC

HANEY CECIL D sold $361K of THC

HANEY CECIL D sold 1,300 shares of TENET HEALTHCARE CORP (THC) at $278.03 ($0.36M total) on 2026-08-24.

Original reporting
SEC EDGAR · HANEY CECIL D
Published Aug 27, 2026, 12:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 27, 2026, 12:14 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$THC
Bearish
medium confidence
Mentioned
$THC
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCBearishLow
01

Why it matters

A director's sale of 1,300 shares for $361k is disclosed for the first time, providing new data for traders monitoring insider activity.

02

Market read

First‑report insider sale; modest size but may influence short‑term sentiment.

03

What to watch

No accompanying corporate news; the director retains a sizable stake.

Relevance 4/10Novelty 4/10Timing: post‑market filing on Aug 26

Background

SEC Form 4 filing discloses insider transactions. Tenet Healthcare (THC) is a NYSE‑listed healthcare services company.

Company-level read

Ticker impact

$THCBearishMedium confidence
Context

Director Haney Cecil D sold 1,300 shares of Tenet Healthcare for $361,439.

Expected impact

Modest short-term downside pressure

Evidence & confidence

Director sales are closely watched; a $361k sale is modest but could trigger sell‑offs among short‑term traders.

Market effects

Sector

Minimal impact on healthcare sector; typical insider transaction.

Regional

None

Global

Low

Counterpoint

What could challenge this read

The sale may be routine portfolio rebalancing, not a negative signal.

Key entities

  • Company
    Tenet Healthcare Corp

    NYSE‑listed healthcare services provider.

  • Insider
    Haney Cecil D

    Director of Tenet Healthcare who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

THC insider trading history →

Related articles

OCT 5
$THCMed

Tenet Healthcare (THC) Refinances Debt On A Fair Value Story That Looks Tightly Priced

Tenet Healthcare (THC) issued $2b in 6.250% senior notes due 2034 to refinance existing debt. Its share price has risen 25.4% in 90 days and 29.7% year-to-date. The company's fair value is estimated at $260, slightly above its current price of $258.62. Management's cost-reduction efforts have lowered contract labor and certain analytics costs, but further margin expansion may be limited.

simplywall.st2 min
SEP 30
$THCMed

Can THC's Cash Flow Support Its Expanding Capital-Return Strategy?

Tenet Healthcare (THC) reported a 27.1% year-over-year increase in operating cash flow to $2.2B in H1 2026, raising its adjusted free cash flow guidance to $1.825B-$2.055B. The company spent $1.4B on share buybacks and increased its repurchase authorization by $2B. THC is balancing buybacks with growth investments, expecting $700M-$800M in capital spending. Peers UHS and HCA also reported significant buybacks and capital investments.

theglobeandmail.com2 min
SEP 26
$THCMed

Is Tenet Healthcare Corporation (THC) A Solid Play on Expanding Ambulatory Business?

Tenet Healthcare (THC) is focusing on its ambulatory business for growth, with BMO Capital Markets noting favorable long-term trends and margins. USPI, Tenet’s ambulatory platform, reported 9.3% revenue growth in Q2. BMO initiated coverage with a Market Perform rating and $265 price target. Hedge funds increased stakes, while short interest declined. Risks include reimbursement changes and competition.

insidermonkey.com3 min
SEP 20
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2 Billion Debt Refinance Means For Shareholders

Tenet Healthcare (THC) completed a $2 billion private placement of senior unsecured notes due 2034 at a 6.250% coupon. Proceeds will redeem $1.5 billion of 2027 secured notes and $0.5 billion of 2028 senior notes, altering its capital structure and interest obligations. Analysts project revenues of $24.1 billion and earnings of $1.6 billion by 2029, with some seeing potential upside.

simplywall.st3 min
SEP 9
$THCMedAI 8/10

What Tenet Healthcare (THC)'s $2b Debt Refinance Means For Shareholders

Tenet Healthcare (THC) priced a $2.0 billion private placement of 6.250% senior notes due 2034, upsized from $1.5 billion, to refinance existing 2027 and 2028 debt. The refinancing replaces secured and partly secured borrowings with unsecured notes, altering the company's debt structure. Investors focus on execution, pricing, and free cash flow, with high debt and earnings declines noted as risks.

simplywall.st2 min